Wearable Health Solutions, Inc.
WHSI · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | -0.00 | 0.07 |
| FCF Yield | -59.99% | -19.38% | -20.26% | -24.78% |
| EV / EBITDA | -2.11 | -1.40 | -2.46 | -3.63 |
| Quality | ||||
| ROIC | 283.32% | 7,495.25% | 457.68% | 37.28% |
| Gross Margin | 35.92% | 45.65% | 37.64% | 59.57% |
| Cash Conversion Ratio | 0.54 | 0.24 | 0.35 | 1.14 |
| Growth | ||||
| Revenue 3-Year CAGR | -18.85% | -3.49% | 11.16% | 6.03% |
| Free Cash Flow Growth | 59.18% | -169.07% | -126.62% | -18,176.07% |
| Safety | ||||
| Net Debt / EBITDA | -1.16 | -0.14 | -0.59 | -1.65 |
| Interest Coverage | -19.89 | -162.48 | -14.29 | -2.42 |
| Efficiency | ||||
| Inventory Turnover | 55.81 | 8.23 | 38.33 | 4.36 |
| Cash Conversion Cycle | -117.84 | 7.87 | -122.55 | -115.48 |